Pharmacy Report Archives - Page 54 of 137 - Becker's Hospital Review

Pharmacist pay by state | Akorn recalls 84 drugs with quality risk | Penicillin drug in shortage | Cuban's pharmacy lowers 35 prices | 10 systems seeking pharmacy leaders | Kaiser scoops Geisinger

April 27, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Average pay for pharmacists, state by state Full story 2. Closed drugmaker recalls all lots of 84 drugs because of quality risk Full story 3. Cuban's pharma company lowers 35…

37 healthcare salaries: Where pharmacists rank | Hospital drug spending to rise up to 3% | FDA approves ALS drug | Lawmakers to vet 4 PBM bills in May | Pluvicto shortage to end in '23: Novartis

April 26, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Hospitals will spend up to 3% more on drugs in 2023, study finds Full story 2. How pharmacist pay compares to 36 other hospital roles Full story 3. FDA approves…

Slowed heartbeat halts cancer drug trial | 20 drug shortages are about 8 years old | Shkreli pops up again in healthcare | Okla. files suit against CVS | Cuban taps digital health partner

April 25, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Irregular heartbeat pauses cancer drug trial Full story 2. Lawsuit accuses CVS Caremark of steering patients, curbing 90-day scripts Full story 3. 20 drugs have been in shortage for nearly…

Cuban hasn't 'f—ed up' pharma yet | UCSF Health exec: Pharmacist scope expansion is 'overdue' | 3 weird results piggyback Ozempic | Tinnitus not a COVID shot risk: CDC | Supreme Court stays abortion pill approval

April 24, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban hasn't 'f—ed up' the pharma industry yet Full story 2. Malnutrition, a sinking face and weird dreams: Ozempic's side effects Full story 3. UCSF pharmacy leader calls pharmacist scope…

Hospital pharmacy execs target burnout | 1,500+ drug infusion pumps recalled | Amoxicillin shortage extends as ED visits peak: Report | 10 systems seeking pharmacy leaders | Cuban taps pharmacy payment teammate

April 20, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA only inspected 6% of foreign drug manufacturers in 2022: Report Full story 2. More hospitals target pharmacy staff burnout Full story 3. Fresenius Kabi recalls drug infusion pumps with leak…

Cuban builds pharmacy network | Bizarre dreams follow Ozempic use | Abortion pill maker settles for $765K | FDA simplifies COVID shot schedule | Cleveland Clinic joins list of systems pulling mask rules

April 19, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban builds a pharmacy network Full story 2. A unique Ozempic side effect: Weird dreams Full story 3. One-third of infectious disease professionals may have conflicts of interest with drug companies Full…

15 most lucrative pharmacies | 13 more drugs in short supply, discontinued | AHA works to protect 340B | Exec pay at Tenet, HCA + CHS | Cleveland Clinic donates site to pharmacy group

April 18, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 15 biggest pharmacies by prescription revenue Full story 2. AHA ramps up 340B protection efforts Full story 3. FDA approves cell therapy for blood cancers Full story 4. Our members have access to…

HHS extends COVID era pharmacy rules | Supreme Court mulls 2 pharma cases | 1 solution to the amoxicillin shortage | mRNA's oncology potential | 5 pharmacy workers sentenced in $126M case

April 17, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Supreme Court to hear False Claims Act pharmacy case: 5 things to know Full story 2. HHS extends some COVID-19 flexibilities for pharmacy workers Full story 3. Strep cases are up…

15 biggest specialty pharmacies | Pharma co. made $3B in '22 from acquired drugs | 2 gene therapies worth $1.9M: ICER draft | 10 systems seeking pharmacy leaders | Mifepristone remains but with caveats

April 13, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Top 15 specialty pharmacies by 2022 revenue Full story 2. This pharma company hasn't licensed a single drug in 15 years, made $3B in 2022 Full story 3. 2 gene therapies…

Biogen imposes more layoffs | White House calls drug combo an 'emerging threat' | HHS shrinks list of drugs subject to inflation rebates | US News' latest medical school ranking

April 12, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Fentanyl-xylazine mix labeled an 'emerging threat' Full story 2. Lawmakers call for FDA to ignore Texas abortion pill ruling Full story 3. Biogen reduces multiple sclerosis team Full story 4. When it comes…